V

Varian

Tech-enabled radiation oncology hardware and software

Head of Customer Success - Laboratory Solutions, NAM, Remote

Full-TimeUpdated on 10/22/2026Deadline 10/27/26
$213.3k - $293.3k+ Commission (if eligible)
Expert
Bachelor's, Master's
Remote in USA
Remote
Customer Experience & SupportCustomer Success
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A bachelor's degree is required.
  • At least 8 years of leadership experience in Customer Success, Customer Experience, Healthcare Services, Laboratory Operations, Commercial Excellence, or a related field is required.
  • Experience within the diagnostics, healthcare technology, medical devices, or life sciences industry is required.
  • Proven success leading customer-focused teams and driving measurable improvements in customer loyalty, retention, and growth is required.
  • Experience building relationships with and influencing executive stakeholders, including laboratory directors, health system leaders, and C-suite executives, is required.
  • Strong business acumen, strategic thinking, and data-driven decision-making capabilities are required.
  • Resilience and emotional intelligence, including the ability to navigate difficult conversations and build trusted relationships, are required.
  • Demonstrated ability to lead through change, develop talent, and build high-performing teams is required.
Responsibilities
  • Improve customer loyalty, satisfaction, and advocacy.
  • Increase customer retention, renewal rates, and long-term partnership value.
  • Drive customer adoption, utilization, and achievement of business outcomes.
  • Reduce customer risk, preventable escalations, and customer churn.
  • Strengthen customer confidence in the company's ability to deliver consistently and reliably.
  • Develop and engage a high-performing Customer Success team.
  • Define and execute a comprehensive Customer Success strategy aligned with business priorities and customer needs.
  • Build, lead, and develop a high-performing team of Customer Success professionals.
  • Create scalable customer engagement models that support customers throughout their lifecycle.
  • Foster a culture of accountability, customer advocacy, and continuous improvement.
  • Own strategic customer partnerships and lead efforts to maximize customer value, retention, and growth.
  • Serve as the voice of the customer across the organization, ensuring customer insights translate into measurable business improvements.
  • Leverage customer insights and feedback to influence product development, service enhancements, process improvements, and business decisions.
  • Partner with Sales and Marketing teams to elevate customer success stories, references, and advocacy programs.
  • Drive initiatives that strengthen customer confidence, trust, and long-term loyalty.
  • Ensure customers realize measurable value from their investment in the company's solutions.
  • Help customers optimize laboratory performance, workflow efficiency, quality outcomes, and operational effectiveness.
  • Support executive business reviews that demonstrate value, strengthen partnerships, and identify opportunities for further success.
  • Partner with customers to develop success plans that align with their strategic goals and priorities.
  • Develop and execute strategies that improve customer retention, renewal rates, loyalty, and lifetime value.
  • Proactively identify at-risk customers and lead cross-functional recovery and mitigation plans.
  • Partner with Sales and Service teams to identify opportunities for growth, expansion, and deeper strategic partnerships.
  • Strengthen executive-level relationships with laboratory leaders, healthcare executives, and key stakeholders.
  • Support strategic account planning and customer growth initiatives by providing customer insights, health indicators, and value realization outcomes.
  • Establish and monitor customer success metrics, including Net Promoter Score, Customer Satisfaction, customer retention, customer health scores, solution adoption and utilization, and escalation trends.
  • Leverage data and analytics to identify opportunities, uncover risks, improve customer outcomes, and drive continuous improvement.
  • Implement scalable processes, tools, and governance models that improve efficiency, consistency, and customer outcomes.
  • Partner closely with Sales, Service, Marketing, Supply Chain, Research and Development, and Finance teams.
  • Align cross-functional teams around customer priorities and business objectives.
  • Influence decisions and investments that improve customer outcomes and strengthen partnerships.
  • Foster a culture of collaboration that places customer success at the center of organizational decision-making.
Desired Qualifications
  • An advanced degree is preferred.

About the company

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, opening a non-cancer market.
  • Telix collaboration and 2026 AI approvals expand Varian's clinical and software pipeline.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium in May 2026, eroding software differentiation.
  • Elekta still attacks Varian's lead in adaptive radiotherapy and premium MR-guided care.
  • If FLASH and non-oncology bets fail by 2028, Varian becomes a commoditized linear-accelerator vendor.

What makes Varian unique

  • Siemens Healthineers gives Varian imaging, radiotherapy, and capital-sales integration globally.
  • Varian's 2026 CE-marked Eclipse AI contouring deepens workflow lock-in across planning.
  • TrueBeam, Halcyon, and Ethos create an installed-base moat hospitals rarely replace.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Holidays
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Wellness Program
  • 401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
Varex Imaging Corporation
Sep 14th, 2026
About Us | Varex Imaging Corporation

We strive to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster

MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.